Egleston

Centerline Biomedical announces New CFO Indrani Egleston

Retrieved on: 
Monday, November 13, 2023
Center line, Internal audit, Radiation, Indrani, University, CFO, Patient, Master, Bachelor of Business Administration, Mergers and acquisitions, Caregiver, Business administration, Egleston, Lead, Nordson Corporation, Case Western Reserve University, Master of Business Administration, Management

CLEVELAND, Nov. 13, 2023 /PRNewswire/ -- Centerline Biomedical, Inc. ("Centerline"), an innovator in cardiovascular visualization and navigation systems, today announced the appointment of Indrani Egleston to the position of Chief Financial Officer (CFO).

Key Points: 
  • CLEVELAND, Nov. 13, 2023 /PRNewswire/ -- Centerline Biomedical, Inc. ("Centerline"), an innovator in cardiovascular visualization and navigation systems, today announced the appointment of Indrani Egleston to the position of Chief Financial Officer (CFO).
  • She most recently served as CFO of Signature Health, a healthcare organization in Northeast Ohio.
  • Prior to Signature Health, Ms. Egleston had advancing financial leadership positions at large public companies in Northeast Ohio, notably Covia (formerly Fairmount Santrol) and Nordson Corporation.
  • "We are delighted to welcome Indrani Egleston to Centerline to lead and grow our financial team.

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against AcelRx Pharmaceuticals, Inc. (ACRX)

Retrieved on: 
Tuesday, June 15, 2021
GME, Egleston, Megan McKenna

On February 16, 2021, the Company disclosed that, on February 11, 2021, the Company received a warning letter from the FDA concerning promotional claims for DSUVIA.

Key Points: 
  • On February 16, 2021, the Company disclosed that, on February 11, 2021, the Company received a warning letter from the FDA concerning promotional claims for DSUVIA.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq.
  • of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected] .

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Frequency, Inc. (FREQ)

Retrieved on: 
Friday, June 4, 2021
Allegation, GME, Egleston, Cause of action, Lawsuit

The Complaint alleges that Frequency and CEO Lucchino misled investors about the Phase 2a study of FX-322.

Key Points: 
  • The Complaint alleges that Frequency and CEO Lucchino misled investors about the Phase 2a study of FX-322.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq.
  • of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected] .

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Washington Prime Group, Inc. (WPG)

Retrieved on: 
Tuesday, May 25, 2021
Egleston, McKenna, Gainey

NEW YORK, May 25, 2021 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Washington Prime Group, Inc. (Washington Prime or WPG) (NYSE: WPG) in the United States District Court for the Southern District of Ohio on behalf of those who purchased or otherwise acquired publicly traded Washington Prime securities between November 5, 2020 and March 4, 2021, inclusive (the Class Period).

Key Points: 
  • NEW YORK, May 25, 2021 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Washington Prime Group, Inc. (Washington Prime or WPG) (NYSE: WPG) in the United States District Court for the Southern District of Ohio on behalf of those who purchased or otherwise acquired publicly traded Washington Prime securities between November 5, 2020 and March 4, 2021, inclusive (the Class Period).
  • The Company further advised that, in an event of default, certain counterparties to the senior notes could accelerate the outstanding indebtedness due .
  • If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq.
  • of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected] .

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against ContextLogic Inc. (WISH)

Retrieved on: 
Thursday, May 20, 2021
Plaintiff, Egleston

When the true details entered the market, the lawsuit claims that investors suffered damages.\nInvestors who purchased or otherwise acquired shares of ContextLogic during the Class Period should contact the Firm prior to the July 16, 2021 lead plaintiff motion deadline.

Key Points: 
  • When the true details entered the market, the lawsuit claims that investors suffered damages.\nInvestors who purchased or otherwise acquired shares of ContextLogic during the Class Period should contact the Firm prior to the July 16, 2021 lead plaintiff motion deadline.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\xc2\xa0 If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq.
  • or Gregory M. Egleston, Esq.
  • of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected] .\nPlease visit our website at http://www.gme-law.com for more information about the firm.\n'

FINAL DEADLINE: Gainey McKenna & Egleston Reminds Investors That A Class Action Lawsuit Has Been Filed Against Sequential Brands Group, Inc. (SQBG)

Retrieved on: 
Friday, May 14, 2021
Plaintiff, Egleston, Class action

When the true details entered the market, the lawsuit claims that investors suffered damages.\nInvestors who purchased or otherwise acquired shares of Sequential Brands during the Class Period should contact the Firm prior to the May 17, 2021 lead plaintiff motion deadline.

Key Points: 
  • When the true details entered the market, the lawsuit claims that investors suffered damages.\nInvestors who purchased or otherwise acquired shares of Sequential Brands during the Class Period should contact the Firm prior to the May 17, 2021 lead plaintiff motion deadline.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\xc2\xa0 If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq.
  • or Gregory M. Egleston, Esq.
  • of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected] .\nPlease visit our website at http://www.gme-law.com for more information about the firm.\n'

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against PureCycle Technologies, Inc. (PCT)

Retrieved on: 
Friday, May 14, 2021
XC2, Egleston

b'NEW YORK, May 14, 2021 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against PureCycle Technologies, Inc. (\xe2\x80\x9cPureCycle\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d) (NASDAQ: PCT) in the United States District Court for the Middle District of Florida on behalf of those who purchased or acquired the securities of PureCycle between November 16, 2020 through May 5, 2021, inclusive (the \xe2\x80\x9cClass Period\xe2\x80\x9d).

Key Points: 
  • b'NEW YORK, May 14, 2021 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against PureCycle Technologies, Inc. (\xe2\x80\x9cPureCycle\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d) (NASDAQ: PCT) in the United States District Court for the Middle District of Florida on behalf of those who purchased or acquired the securities of PureCycle between November 16, 2020 through May 5, 2021, inclusive (the \xe2\x80\x9cClass Period\xe2\x80\x9d).
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\xc2\xa0 If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq.
  • or Gregory M. Egleston, Esq.
  • of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected] .\nPlease visit our website at http://www.gme-law.com for more information about the firm.\n'

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against ChemoCentryx, Inc. (CCXI)

Retrieved on: 
Monday, May 10, 2021
Plaintiff, Egleston

When the true details entered the market, the lawsuit claims that investors suffered damages.\nInvestors who purchased or otherwise acquired shares of ChemoCentryx during the Class Period should contact the Firm prior to the July 6, 2021 lead plaintiff motion deadline.

Key Points: 
  • When the true details entered the market, the lawsuit claims that investors suffered damages.\nInvestors who purchased or otherwise acquired shares of ChemoCentryx during the Class Period should contact the Firm prior to the July 6, 2021 lead plaintiff motion deadline.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\xc2\xa0 If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq.
  • or Gregory M. Egleston, Esq.
  • of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected] .\nPlease visit our website at http://www.gme-law.com for more information about the firm.\n'

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Skillz, Inc. (SKLZ)

Retrieved on: 
Monday, May 10, 2021
Plaintiff, Egleston, Class action

When the true details entered the market, the lawsuit claims that investors suffered damages.\nInvestors who purchased or otherwise acquired shares of Skillz during the Class Period should contact the Firm prior to the July 7, 2021 lead plaintiff motion deadline.

Key Points: 
  • When the true details entered the market, the lawsuit claims that investors suffered damages.\nInvestors who purchased or otherwise acquired shares of Skillz during the Class Period should contact the Firm prior to the July 7, 2021 lead plaintiff motion deadline.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\xc2\xa0 If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq.
  • or Gregory M. Egleston, Esq.
  • of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected] .\nPlease visit our website at http://www.gme-law.com for more information about the firm.\n'

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Acadia Pharmaceuticals Inc. (ACAD)

Retrieved on: 
Tuesday, April 20, 2021
XC2, Egleston, Acadia Pharmaceuticals, XE-class submarine

b'NEW YORK, April 20, 2021 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Acadia Pharmaceuticals Inc. (\xe2\x80\x9cAcadia\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d) (NASDAQ: ACAD) in the United States District Court for the Southern District of California on behalf of those who purchased or acquired the securities of Acadia between June 15, 2020 and April 4, 2021, inclusive (the \xe2\x80\x9cClass Period\xe2\x80\x9d).

Key Points: 
  • b'NEW YORK, April 20, 2021 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Acadia Pharmaceuticals Inc. (\xe2\x80\x9cAcadia\xe2\x80\x9d or the \xe2\x80\x9cCompany\xe2\x80\x9d) (NASDAQ: ACAD) in the United States District Court for the Southern District of California on behalf of those who purchased or acquired the securities of Acadia between June 15, 2020 and April 4, 2021, inclusive (the \xe2\x80\x9cClass Period\xe2\x80\x9d).
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\xc2\xa0 If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq.
  • or Gregory M. Egleston, Esq.
  • of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected] .\nPlease visit our website at http://www.gme-law.com for more information about the firm.\n'